ArticleJournal of orthopaedic translation2026

Silencing SFRP1 in bone mesenchymal stem cells alleviates pediatric B-ALL-driven bone loss by activating Wnt/β-catenin signaling.

Mengxia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.